Altered Cardiac Autonomic Function May Precede Insulin Resistance in Metabolic Syndrome

American Journal of Medicine

Volumn 123, Issue 5, 2010, Pages 432-438

  Chang, Chih Jen ^a,b   Yang, Yi Ching ^a,b   Lu, Feng Hwa ^a,b   Lin, Thy Sheng ^a   Chen, Jia Jin ^c   Yeh, Tzung Lieh ^a   Wu, Chih Hsing ^b   Wu, Jin Shang ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Cardiac autonomic function; Epidemiology; Heart rate variability; Insulin resistance; Metabolic abnormality

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; EXPIRATORY FLOW; FEMALE; HEART AUTOMATICITY; HEART FUNCTION; HOMEOSTASIS; HUMAN; HYPERPNEA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PEAK INSPIRATORY FLOW; POWER SPECTRUM; PRIORITY JOURNAL; STANDING;

ADULT; AUTONOMIC NERVOUS SYSTEM; ELECTROCARDIOGRAPHY; FEMALE; HEART; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED;

EID: 77950596948     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.07.031     Document Type: Article

References (32)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
2. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (2005) 2735-2752
3. Boyko E.J., de Courten M., Zimmet P.Z., et al. Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius. Diabetes Care 23 (2000) 1242-1248
4. Lorenzo C., Okoloise M., Williams K., et al. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio Heart Study. Diabetes Care 26 (2003) 3153-3159
5. Wang J.J., Qiao Q., Miettinen M.E., et al. The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care 27 (2004) 2429-2437
6. Hunt K.J., Resendez R.G., Williams K., et al. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110 (2004) 1251-1257
7. Malik S., Wong N.D., Franklin S., et al. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care 28 (2005) 690-693
8. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 (2005) 385-390
9. Tan C.E., Ma S., Wai D., et al. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 27 (2004) 1182-1186
10. Mancia G., Bousquet P., Elghozi J.L., et al. The sympathetic nervous system and the metabolic syndrome. J Hypertens 25 (2007) 909-920
11. Esler M., Straznicky N., Eikelis N., et al. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48 (2006) 787-796
12. Task force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability standards of measurement, physiological interpretation, and clinical use. Circulation 93 (1996) 1043-1065
13. Huggett R.J., Burns J., Mackintosh A.F., and Mary D.A. Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension 44 (2004) 847-852
14. Grassi G., Dell'Oro R., Quarti-Trevano F., et al. Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 48 (2005) 1359-1365
15. Brunner E.J., Hemingway H., Walker B.R., et al. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation 106 (2002) 2659-2665
16. Liao D., Sloan R.P., Cascio W.E., et al. Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study. Diabetes Care 21 (1998) 2116-2122
17. Lu F.H., Yang Y.C., Wu J.S., et al. A population-based study of the prevalence and associated factors of diabetes mellitus in southern Taiwan. Diabet Med 15 (1998) 564-572
18. Paffenbarger Jr. R.S., Blair S.N., Lee I.M., and Hyde R.T. Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc 25 (1993) 60-70
19. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
20. Masuo K., Mikami H., Ogihara T., and Tuck M.L. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens 10 (1997) 77-83
21. Flaa A., Aksnes T.A., Kjeldsen S.E., Eide I., and Rostrup M. Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism 57 (2008) 1422-1427
22. Carnethon M.R., Prineas R.J., Temprosa M., et al., Diabetes Prevention Program Research Group. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care 29 (2006) 914-919
23. Jamerson K.A., Julius S., Gudbrandsson T., et al. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 21 (1993) 618-623
24. Egan B.M. Neurohumoral, hemodynamic and microvascular changes as mechanisms of insulin resistance in hypertension: a provocative but partial picture. Int J Obes 15 (1991) 133-139
25. Baron A.D., Laakso M., Brechtel G., et al. Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity. J Clin Endocrinol Metab 70 (1997) 1525-1533
26. Julius S., Gundrandsson T., Jamerson K., and Andersson O. The interconnection between sympathetics, microcirculation and insulin resistance in hypertension. Blood Press 1 (1992) 9-19
27. Benthem L., Keizer K., Wiegman C.H., et al. Excess portal venous long-chain fatty acids induce syndrome X via HPA axis and sympathetic activation. Am J Physiol-Endocrinol Metab 279 (2000) E1286-E1293
28. Mackintosh V.S., Phan C.T., Mortimer B.C., and Redgrave T.G. Vasoactive mediators affect the clearance of lipids from emulsion models of plasma lipoproteins in rats. J Cardiovasc Pharmacol 27 (1996) 447-454
29. Wu J.S., Lu F.H., Yang Y.C., et al. Epidemiological study on the effect of pre-hypertension and family history of hypertension on cardiac autonomic function. J Am Coll Cardiol 51 (2008) 1896-1901
30. Wu J.S., Lu F.H., Yang Y.C., et al. Epidemiological evidence of altered cardiac autonomic function in overweight, but not underweight subjects. Int J Obes Relat Metab Disord 32 (2008) 788-794
31. Wu J.S., Yang Y.C., Lin T.S., et al. Epidemiological evidence of altered cardiac autonomic function in subjects with impaired glucose tolerance but not isolated impaired fasting glucose. J Clin Endocrinol Metab 92 (2007) 3885-3889
32. Moller D.E., and Kaufman K.D. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 56 (2005) 45-62